By Dean Seal
Shares of Teladoc Health slumped after the company logged a wider fourth-quarter loss than analysts had expected and provided tepid guidance for 2025.
The stock was down 18% at $9 in early trading. Shares are now teetering into negative territory year-to-date. They were trading at $15.16 this time a year ago.
The virtual care company reported a loss of 28 cents a share for the fourth quarter. Analysts polled by FactSet had been expecting a smaller 26-cent per-share loss. Revenue of $640.5 million for the quarter was $1 million higher than projected.
Teladoc guided for $2.47 billion to $2.58 billion in revenue in 2025, along with a net loss of 50 cents to $1.10 a share. The midpoint of those ranges were weaker than analyst projections, which have since been adjusted to reflect lower sales and a wider loss, according to FactSet.
The current year is a known transition year for Teladoc, and the stock decline likely reflects that guidance is heavily weighted toward the back-end of the year, Stifel analysts said in a research note.
"We expect TDOC's stock price to remain volatile given the absence of near-term catalysts and a meaningful short interest," the analysts said.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
February 27, 2025 10:00 ET (15:00 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。